Sort
326,823 grants matching “clinical trial”
Drug Combination Signatures for Prediction and Mitigation of Toxicity
$1,899,685Srinivas Ravi V Iyengar · Icahn School Of Medicine At Mount Sinai · U54 · FY2016 · HG
Drug Combination Signatures for Prediction and Mitigation of Toxicity
$1,899,685Srinivas Ravi V Iyengar · Icahn School Of Medicine At Mount Sinai · U54 · FY2017 · HG
Drug Combination Signatures for Prediction and Mitigation of Toxicity
$1,899,685Srinivas Ravi V Iyengar · Icahn School Of Medicine At Mount Sinai · U54 · FY2015 · HG
Drug Combination Signatures for Prediction and Mitigation of Toxicity
$1,899,685Srinivas Ravi V Iyengar · Icahn School Of Medicine At Mount Sinai · U54 · FY2019 · HG
Biology and Therapy of High Risk Neuroblastoma
$1,899,503Robert C Seeger · Children'S Hospital Of Los Angeles · P01 · FY2007 · CA
Genetics and Biology of Pancreatic Duct Adenocarcinoma
$1,899,242Ronald Anthony Depinho · Dana-Farber Cancer Inst · P01 · FY2010 · CA
Developmental Funds
$1,899,206Lawrence Corey · Fred Hutchinson Cancer Research Center · P30 · FY2015 · CA
Normal and Neoplastic Growth in the Brain
$1,899,162Suzanne J Baker · St. Jude Children'S Research Hospital · P01 · FY2019 · CA
Analysis of high dimensional genomic dataset to reveal mechanistic insights on divergent outcomes of head and neck cancer using system biology modeling coupled with experimental validation
$1,899,042Jing Hong Wang · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · DE
IGF::OT::IGF PHARMACOLGY AND TOXICOLOGY STUDIES OF AMAKACIN AND SUTEZOLID, AND SUPPORT THE DEVELOPMENT OF BIOMARKER AND MITOCHONDRIAL TOXICITY ASSAYS
$1,898,936Jon Carl Mirsalis · Sri International · N01 · FY2014 · AI
Prenatal Environment And Child Health (PEACH) in ECHO
$1,898,891Rebecca Jean Schmidt · University Of California At Davis · UG3 · FY2024 · OD
Sedation Management in Pediatric Patients with Acute Respiratory Failure
$1,898,890Martha Aq Curley · University Of Pennsylvania · U01 · FY2011 · HL
Boston University Alzheimer's Disease Center
$1,898,738Neil W. Kowall · Boston University Medical Campus · P30 · FY2019 · AG
Boston University Alzheimer's Disease Center
$1,898,738Neil W. Kowall · Boston University Medical Campus · P30 · FY2020 · AG
A Pragmatic Trial of An Adaptive eHealth HIV Prevention Program for Diverse Adolescent MSM
$1,898,521Brian Mustanski · Northwestern University At Chicago · U01 · FY2018 · MD
SOUTHEAST CANCER CONTROL COSORTIUM, INC
$1,898,488Southeast Cancer Control Consortium · U10 · FY2004 · CA
Mayo Alzheimer's Disease Research Center
$1,898,428Ronald C Petersen · Mayo Clinic Rochester · P50 · FY2015 · AG
EARLY TMT/RETINOPATHY OF PREMATURITY (ETROP)- COORD CTR
$1,898,403Robert J Hardy · University Of Texas Hlth Sci Ctr Houston · U10 · FY2006 · EY
In Situ Tumor Vaccination with a Nano-oligo Therapeutic to Induce Whole-body Antitumor Immune Response
$1,898,361Worapol Ngamcherdtrakul · Pdx Pharmaceuticals, Inc. · R44 · FY2021 · CA
RP2: Targeting Estrogen receptor and DNA damage repair disparities in African American and Hispanic/Latino breast cancer using Patient-Derived Breast Cancer Xenografts
$1,898,211Matthew J Ellis · Baylor College Of Medicine · U54 · FY2018 · CA
Botswana-Harvard T.H. Chan School of Public Health AIDS Initiative Partnership CTU
$1,898,133Shahin Lockman · Harvard University D/B/A Harvard School Of Public Health · UM1 · FY2024 · AI
Activation of Plasmacytoid Dendritic Cells (pDCs) to Induce Antitumor Activity
$1,898,043Patrick Hwu · University Of Tx Md Anderson Can Ctr · P01 · FY2012 · CA
Colaboracion Evita: HPV-Related Cancer Prevention Partnership Center
$1,897,572Margaret M Madeleine · Fred Hutchinson Cancer Center · U54 · FY2023 · CA
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy of ManNAc in Subjects with GNE Myopathy
$1,897,534Anthony Arnold Amato · Brigham And Women'S Hospital · U01 · FY2017 · AR
Cellular and Molecular Mechanisms of Acute Lung Injury in Sickle Cell Disease
$1,897,529Clinton H. Joiner · Emory University · U01 · FY2013 · HL